Botulinum toxin A (Ipsen)

A型肉毒毒素（Ipsen）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameBotulinum toxin A (Ipsen)
Drug Alias NameAbobotulinumtoxinAAzzalureReloxinDysport吉适 +[7] 
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsNasolabial fold wrinklesUpper and lower limb spasticityGlabellar lines +[30] 
Global Approved IndicationsFacial DermatosesDystonia
Approved Indications in ChinaFacial Dermatoses
Original Approved Country/TerritoryUnited States
Original Approved Date2009/04/29
Country/TerritoryCzechiaBelgiumBulgaria +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Active CompaniesIpsenUniversity Of MiamiIpsen Biopharm Ltd +[4] 
Inactive CompaniesBeaufour-Ipsen (Tianjin) Pharmaceutical Co LtdCairo UniversityGalderma R&D +[10] 
Active IndicationsNasolabial fold wrinklesUpper and lower limb spasticityFacial Dermatoses +[8] 
Inactive IndicationsGlabellar linesHealthy AgingWounds and Injuries +[22] 

Other Information

ATC CodeM03AX01
Related LinksWikipediaKEGG